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Bunyamwera virus NSs protein is involved in the inhibition of cellular transcription and the
interferon (IFN) response, and it interacts with the Med8 component of Mediator. A spontaneous
mutant of a recombinant NSs-deleted Bunyamwera virus (rBUNdelNSs2) was identified and
characterized. This mutant virus, termed mBUNNSs22, expresses a 21 aa N-terminally truncated
form of NSs. Like rBUNdelNSs2, mBUNNSs22 is attenuated in IFN-deficient cells, and to a
greater extent in IFN-competent cells. Both rBUNdelNSs2 and mBUNNSs22 are potent IFN
inducers and their growth can be rescued by depleting cellular IRF3. Strikingly, despite encoding
an NSs protein that contains the Med8 interaction domain, mBUNNSs22 fails to block RNA
polymerase II activity during infection. Overall, our data suggest that both the interaction of NSs
with Med8 and a novel unidentified function of the NSs N-terminus, seem necessary for
Bunyamwera virus to counteract host antiviral responses.
Bunyamwera virus (BUNV) is the type species of both
the genus Orthobunyavirus and the family Bunyaviridae,
members of which are important human pathogens causing
diseases such as febrile illness and haemorrhagic fever.
Bunyaviruses possess a tri-segmented, negative-sense RNA
genome that encodes four structural proteins: the viral
RNA-dependent RNA polymerase (L protein) on the large
(L) segment, two glycoproteins (Gn and Gc) on the medium
(M) segment, and the nucleoprotein (N) on the small (S)
segment. In addition, orthobunyaviruses encode one or two
non-structural proteins, NSm on the M segment and NSs
(for most but not all orthobunyaviruses; Mohamed et al.,
2009) on the S segment (Nichol et al., 2005; Schmaljohn &
Hooper, 2001).
The NSs protein is the major viral interferon (IFN)
antagonist involved in evading host innate immune
responses (Bridgen et al., 2001; Weber et al., 2002). NSs
was shown to interact with Med8 (Le´onard et al., 2006), a
component of the Mediator complex that is involved in
regulating the activity of cellular RNA polymerase II
(RNAPII; Malik & Roeder, 2005). During infection with
wild-type (wt) BUNV cellular RNAPII is degraded, presum-
ably as a result of the interaction between NSs and Med8
(Le´onard et al., 2006). Thus, NSs is thought to antagonize the
IFN response by a general block of transcription of all host
genes including IFN. This general transcriptional block
caused by NSs is at least partially responsible for the observed
shut off of host cell protein synthesis (Bridgen et al., 2001;
Thomas et al., 2004; Hart et al., 2008).
The N and NSs proteins are translated from overlapping
open reading frames (ORFs) in a single mRNA transcribed
from the S segment. To examine the role of NSs in
infection, a recombinant virus lacking NSs (rBUNdelNSs2)
was created in which NSs expression was abrogated by
changing the tandem AUG initiation codons to ACG
codons and converting codon 3 (serine) to a stop codon. In
addition, codons 4 and 5 were changed from leucine to
proline (Bridgen et al., 2001). Subsequently, a potential
downstream AUG-initiation codon at position 30 was
changed to ACG (Fig. 1a; Hart et al., 2008). All the
mutations introduced to create rBUNdelNSs2 are silent
with respect to the N ORF.
During routine analysis of newly prepared viral stocks
derived from isolated plaques, lysates of infected BHK cells
were checked for expression of NSs by Western blotting as
described previously (Blakqori et al., 2009). As expected,
wtBUNV expressed the 11 kDa NSs protein (Fig. 1b), but
surprisingly one particular stock of the NSs-deleted virus,
subsequently named mBUNNSs22, expressed a ~9 kDa
protein that cross-reacted with BUNV NSs antiserum
(Fig. 1b). Analysis of the nucleotide sequence encompassing
the N and NSs start codons in the S segment revealed that
codon 22 in the NSs ORF was changed from GUG to AUG
[nt 168–170 in the (+) sense S RNA], creating a new
translation initiation codon in the NSs gene (Fig. 1a). The
NSs protein resulting from initiation at this new AUG
(NSs22 protein) is predicted to have a molecular mass of
8.76 kDa, which is consistent with the observed size
difference compared with full-length NSs (Fig. 1b). The
mutation also led to a conservative amino acid change in the
N protein from arginine to histidine at residue 28 (Fig. 1a).
Arginine 28 is not conserved between different orthobun-
yavirus N proteins and mutations at this position have only
a minor impact on virus replication (Eifan & Elliott, 2009).
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Treatment of infected cells with the proteasome inhibitor
MG132 (10 mM) leads to accumulation and therefore more
sensitive detection of NSs (Hart et al., 2008). We compared
NSs expression in cells infected with another rBUNdelNSs2
stock to those infected with wt- and mBUNNSs22 viruses
in the presence of MG132 (Fig. 1c). Whereas the latter two
lysates showed bands corresponding to full-length and
truncated NSs, respectively, no NSs protein could be
detected in extracts of rBUNdelNSs2-infected cells. In
addition, nucleotide sequence analysis of the S segment of
rBUNdelNSs2 confirmed that only the mutations that were
originally introduced to create the NSs-deletion mutant
were present (codons 1–5 and 30; Bridgen et al., 2001; Hart
et al., 2008), and codon 22 remained as GUG.
Multicycle virus growth in BHK cells was analysed as
described previously (Shi et al., 2009) at both 33 uC, the
temperature at which viral stocks are prepared, and 37 uC,
the temperature used for most experimental work with
BUNV. At both temperatures both mutant viruses grew to
titres about 10-fold lower than wt virus (Fig. 1d, e).
Interestingly, mBUNNSs22 grew to slightly lower titres than
delNSs at 33 uC (4.46105 p.f.u. ml21 vs 1.56106 p.f.u. ml21;
Fig. 1d), but slightly higher titres at 37 uC (46106 p.f.u. ml21
vs 7.66105 p.f.u. ml21; Fig. 1e), an observation that was
consistent in repeated experiments (data not shown).
Although mBUNNSs22 was attenuated in the partially
IFN-deficient BHK cell line (Habjan et al., 2009), we
speculated that this virus may be less sensitive to the host
IFN response than rBUNdelNSs2, since it expressed a large
fragment of the viral IFN antagonist. In IFN-competent
A549 cells, mBUNNSs22, like rBUNdelNSs2, was severely
attenuated, and grew to titres approximately 1000-fold
lower than wtBUNV (Fig. 2a). The levels of IFN induction
in A549 cells were analysed using the biological assay
described by Mohamed et al. (2009). Briefly, the medium
from infected A549 cells was collected at 24 h post-
infection (p.i.), UV-inactivated and then used to induce
protection of indicator cells from encephalomyocarditis
virus (EMCV) infection. Infection by rBUNdelNSs2 or
mBUNNSs22 resulted in secretion of significantly higher
amounts of biologically active IFN than infection with
wtBUNV (Fig. 2b), indicating that mBUNNSs22, like
rBUNdelNSs2, is a strong IFN inducer. Finally, we
compared the plaque phenotypes of wtBUNV,
mBUNNSs22 and rBUNdelNSs2 in A549 cells and in
A549-NPro cells that express the bovine viral diarrhea virus
NPro protein (Hale et al., 2009). NPro induces protea-
some-mediated degradation of IRF-3, a cellular transcrip-
tion factor essential for the production of IFN-b in
response to virus infection (Hilton et al., 2006). The cells
were infected with approximately 50 p.f.u. of virus and
stained after 5 days incubation at 37 uC. Only wt virus
produced plaques on naı¨ve A549 cells, but all three viruses
formed plaques in A549-NPro cells (Fig. 2c). Thus, the
attenuation of mBUNNSs22 in naı¨ve A549 cells can be
Fig. 1. Characterization of a mutant
Bunyamwera virus that expresses an N-
terminally truncated NSs protein. (a)
Schematic of S segment RNA sequences
surrounding the N and NSs ORF start codons
for wtBUNV, rBUNdelNSs2 (delNSs2) and
mBUNNSs22 (NSs22). Shown are nt 83–119
and 162–197 of the S (+) RNA. The
numbering of the relevant codons is indicated,
AUG start codons are underlined and bold,
and an asterisk (*) marks a stop codon. Amino
acid sequences for N and NSs are shown
above and below the RNA sequences,
respectively. (b) Western blot analysis of
BHK cells infected with wtBUNV (wt) or
mBUNNSs22 (NSs22) or mock-infected (M).
Strips of the blot were probed with the
antibodies indicated on the right; size markers
are indicated on the left. (c) Western blot
analysis of BHK cells infected with wtBUNV,
mBUNNSs22 (22), rBUNdelNSs2 (del) or
mock-infected. MG132 (10 mM) was added
to the medium at 5 h p.i. and cell extracts were
prepared at 12 h p.i. (d, e) Multi-step growth
curves of wtBUNV, rBUNdelNSs2 and
mBUNNSs22 in BHK cells at 33 6C (d) and
37 6C (e). Shown are mean values of triplicate
infections.
BUNV truncated NSs protein
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relieved by degradation of IRF-3, suggesting that
mBUNNSs22, like rBUNdelNSs2, had lost its IFN-ant-
agonist function.
The mechanism by which wtBUNV blocks the IFN
response has been proposed to involve NSs-mediated
blocking of phosphorylation of serine-2 in the heptad
repeat in the RNAPII C-terminal domain (CTD; Thomas
et al., 2004; Le´onard et al., 2006). To test whether
mBUNNSs22 was impaired in its ability to inhibit serine-
2 phosphorylation, BHK cells were infected with wtBUNV,
rBUNdelNSs or mBUNNSs22 and cell lysates analysed by
Western blotting using antibodies specific for the serine-2
phosphorylated CTD of RNAPII (Ser2-P RNAPII; H5,
Covance Research Products) or for RNAPII irrespective of
its phosphorylation state (8WG16; Covance). As observed
consistently in repeated experiments, during wtBUNV
infection an increase in the signal for NSs correlated with a
decrease in the signal for Ser2-P RNAPII and later also
RNAPII in any phosphorylation state. Although it cannot
be concluded per se that NSs is directly responsible for the
degradation of RNAPII, it seems plausible that NSs
disturbs serine-2 phosphorylation of the CTD and this
leads to a stalled RNAPII complex, which is then targeted
for degradation. Generally, no decrease in RNAPII levels
was observed in rBUNdelNSs2-infected cell extracts where
no NSs was expressed (Fig. 3a), confirming that NSs is
responsible for RNAPII degradation. In extracts of cells
infected with mBUNNSs22 a clear signal for the truncated
NSs protein was detected, but no decrease in RNAPII levels
could be observed (Fig. 3a). These results confirmed that
mBUNNSs22 had lost the ability to block phosphorlyation
or induce degradation of RNAPII and thus to counteract
the host IFN response.
Previous analyses had mapped the Med8-interacting
domain in NSs to residues 83–91, and showed that NSs
proteins with N-terminal truncations of 10, 40 or 49 aa
could still interact with Med8 (Le´onard et al., 2006). This
implies that the truncated NSs22 protein expressed by the
mutant virus would be capable of interacting with Med8,
and yet no degradation of RNAPII could be detected.
Therefore, the interaction between the NSs C terminus and
Med8, though essential, seems not to be sufficient to block
phosphorylation of CTD-Ser2 or to promote degradation
of RNAPII during infection.
The ability of mBUNNSs22 to shut off host protein
synthesis was compared to that of wt and rBUNdelNSs2
viruses in A549 and Vero cells (Fig. 3b) by metabolic
labelling with [35S]methionine as described previously
(Le´onard et al., 2006). Whereas wtBUNV caused host
protein synthesis shut off in both cell types, hardly any shut
off was observed for rBUNdelNSs2 or mBUNNSs22
(Fig. 3b). The shut off observed in wtBUNV-infected cells
is the result of the effect of NSs on both cellular translation
and transcription (Bridgen et al., 2001; Hart et al., 2008;
Thomas et al., 2004) and the blocking of RNAPII activity is
a major contributing factor. Thus, the results in Fig. 3(b)
correlate well with those in Figs 2 and 3(a), and are in
agreement with the hypothesis that inability of NSs to
block RNAPII activity prevents virus-mediated shut off of
host cell gene expression and consequently leads to the
induction of IFN.
Compared to the amount of N protein, the level of NSs22
protein produced by mBUNNSs22 appeared to be lower
than that of full-length NSs made by wtBUNV, at least for
the first 12 h of infection (Figs 1b and 3a). This difference
Fig. 2. mBUNNSs22 is attenuated in IFN-
competent cells and is a potent IFN inducer.
(a) Multi-step growth curves of wtBUNV,
rBUNdelNSs2 and mBUNNSs22 virus in
A549 cells. Shown are mean values of
triplicate infections. (b) Levels of IFN induced
in A549 cells after 24 h infection with
wtBUNV, rBUNdelNSs2 or mBUNNSs22.
The relative IFN content of medium from
infected cells was measured by comparing
the dilution that could protect indicator cells
from EMCV infection. (c) Plaque formation in
IFN-competent A549 cells (left panels) and
IFN-deficient A549-NPro cells (right panels).
Cells were infected with wtBUNV,
rBUNdelNSs2 or mBUNNSs22 as indicated
and were stained for plaque formation after
5 days incubation at 37 6C.
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was consistently observed in repeated Western blot
experiments (not shown) and may reflect a lower or
slower rate of synthesis of the truncated protein.
Alternatively, it could be the result of increased instability
of the mutant protein. Two observations seem to point
towards the latter explanation: (i) the NSs22 protein was
not consistently detected in plasmid-transfected cells (data
not shown), and (ii) the C-terminally truncated NSs
protein expressed by BUNNSs-T83 (Le´onard et al., 2006) is
also difficult to detect in infected cells (unpublished
observations).
The first NSs-deletion virus generated, rBUNdelNSs9a, was
found to express a truncated NSs protein (NSs30) from the
AUG at codon 30, but this virus had the same phenotype in
BHK cells as the subsequently made rBUNdelNSs2 virus
(Bridgen et al., 2001; Hart et al., 2008) and was a potent
inducer of IFN (Weber et al., 2002). The data presented
here are in agreement with, and extend, those obtained for
rBUNdelNSs9a. It seems unlikely that NSs30 is expressed
during wtBUNV infection since most ribosomes will
initiate either at the N start codon [that is in a weak
‘Kozak’ sequence (Kozak, 2002)] or at the NSs start codon
(that is in a slightly stronger Kozak context). On the other
hand, the start codon to initiate NSs22 translation is in a
relatively strong Kozak context even though it was not
originally an initiation codon. This may explain why the
mutation that rescued truncated-NSs expression occurred
at this site rather than reversion of codon 30.
The fact that mBUNNSs22 arose spontaneously suggests a
selective pressure for some function of NSs to be regained by
the virus. Our results indicate that although mBUNNSs22
expresses a large part of the viral IFN antagonist protein, this
mutant virus behaves indistinguishably from rBUNdelNSs2
in its inability to inhibit IFN induction. The selective
pressure must thus be for another function of NSs, which
could be to inhibit protein translation (Hart et al., 2008), to
counteract induction of apoptosis (Kohl et al., 2003) or to
regulate the viral RNA polymerase (Weber et al., 2001).
Attempts to examine the effect of NSs22 on viral polymerase
activity using the minigenome assay (Weber et al., 2001)
were thwarted by the instability of the truncated protein,
though other means to measure this effect are currently
being explored.
The results presented in Figs 2 and 3 demonstrate the
requirement of the first 21 aa of the NSs protein for its
IFN-antagonist function. Although the interaction between
NSs and Med8 is thought to be involved in blocking host
Fig. 3. mBUNNSs22 does not degrade
RNAPII or cause shut off of host protein
synthesis. (a) Western blot analysis of BHK
cells infected with wtBUNV, rBUNdelNSs2,
mBUNNS22 or mock-infected, and harvested
at the indicated times p.i. Size markers are
indicated on the left, and antibodies used on
the right. a-RNAPII, antibody against RNAPII-
CTD, regardless of its phosphorylation state;
a-Ser2-P, antibody specific for serine-2-phos-
phorylated CTD of RNAPII. (b) Metabolic
labelling of infected cells. A549 cells (top
panel) and Vero cells (bottom panel) were
infected with wtBUNV, rBUNdelNSs2,
mBUNNSs22 or were mock-infected. Cells
were labelled with [35S]methionine for 1 h prior
to the indicated time p.i., and cell lysates were
analysed by SDS-PAGE. Viral proteins and
their sizes are indicated on the right.
BUNV truncated NSs protein
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transcription (Le´onard et al., 2006), the presence of the
interacting domain in NSs (located between aa 83 and 91;
Le´onard et al., 2006) is apparently in itself not enough to
lead to the blocking of RNAPII activity. This suggests that
the interaction with Med8 alone is not sufficient to inhibit
host transcription and that other factors requiring the NSs
N terminus are involved in this mechanism. The identity of
these factors and the mechanism of RNAPII inhibition are
currently under investigation.
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